SCHEMBL3849997

SCHEMBL3849997

CS(=O)(=O)c1ccc(-c2ccnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4-c4ccc(F)cc4)cc23)s1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.39
CA1 P00915 5/20 0.39
CA2 P00918 5/20 0.39
CA9 Q16790 5/20 0.39
PTGS2 P35354 2/20 0.35
PIK3CA P42336 4/20 0.35
MAPK14 Q16539 3/20 0.33
CSNK1D P48730 2/20 0.33
CSNK1E P49674 2/20 0.33
MAPK8 P45983 1/20 0.32
MAPK9 P45984 1/20 0.32
MAPK10 P53779 1/20 0.32
ACVR1 Q04771 3/20 0.32
MAPK13 O15264 1/20 0.32
MAPK12 P53778 1/20 0.32
KCNH2 Q12809 1/20 0.32
MAPK11 Q15759 1/20 0.32
AAK1 Q2M2I8 1/20 0.31
PIK3CD O00329 1/20 0.31
PIK3CB P42338 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3854489 0.89 PTGS2 (0.35) CA12CA1CA2CA9PTGS2
SCHEMBL3850069 0.88 CA12 (0.43) CA12CA1CA2CA9PIK3CA
SCHEMBL3853751 0.87 CA12 (0.40) CA12CA1CA2CA9PIK3CA
SCHEMBL3849386 0.85 MAPK14 (0.37) PIK3CAMAPK14CSNK1DCSNK1EACVR1
SCHEMBL3850001 0.85 CA12 (0.33) CA12CA1CA2CA9PTGS2
SCHEMBL3846708 0.82 PTGS1 (0.34) CA12CA1CA2CA9PTGS2
SCHEMBL3854275 0.82 CYP3A4 (0.33) CA12CA1CA2CA9PIK3CA
SCHEMBL3846261 0.81 CA12 (0.34) CA12CA1CA2CA9PIK3CA
SCHEMBL3846696 0.81 KIT (0.35) CA12CA1CA2CA9PTGS2
SCHEMBL3846935 0.81 KIT (0.34) CA12CA1CA2CA9PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed